OTCPK:RXMD

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Progressive Care, Inc., through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida.


Snowflake Analysis

Mediocre balance sheet with weak fundamentals.

Share Price & News

How has Progressive Care's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: RXMD's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-2.6%

RXMD

1.1%

US Consumer Retailing

2.5%

US Market


1 Year Return

-29.3%

RXMD

16.5%

US Consumer Retailing

8.4%

US Market

Return vs Industry: RXMD underperformed the US Consumer Retailing industry which returned 16.5% over the past year.

Return vs Market: RXMD underperformed the US Market which returned 8.4% over the past year.


Shareholder returns

RXMDIndustryMarket
7 Day-2.6%1.1%2.5%
30 Day26.7%-0.3%5.1%
90 Day9.8%8.9%2.0%
1 Year-29.3%-29.3%18.6%16.5%10.9%8.4%
3 Year146.0%146.0%38.1%30.3%30.5%21.9%
5 Year814.8%814.8%59.1%42.7%56.9%39.2%

Price Volatility Vs. Market

How volatile is Progressive Care's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Progressive Care undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Progressive Care is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Progressive Care has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Next Steps

  • Take a look at our analysis of RXMD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • When valuing a company like this, investors focus more on how they perceive the size of the opportunity, the company's ability to deliver and scale, and the strength of the team. While we are not analysing this type of data at the moment, if you don’t know where to start, we recommend reading through Progressive Care regulatory filings here.
  • Explore potentially undervalued companies in the Consumer Retailing industry.

Future Growth

How is Progressive Care forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

7.3%

Forecasted Consumer Retailing industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Progressive Care has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of RXMD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Progressive Care's filings and announcements here.
  • Explore growth companies in the Consumer Retailing industry.

Past Performance

How has Progressive Care performed over the past 5 years?

6.5%

Historical Consumer Retailing annual earnings growth


In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Progressive Care has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.


Next Steps

Financial Health

How is Progressive Care's financial position?


In this section we usually analyse Progressive Care's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Progressive Care has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.


Next Steps

  • Take a look at our analysis of RXMD’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • Investors tend to look at the financial health of a company this size in order to assess the sustainability of its current operations. While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website.
  • Financial health is measured at one point in time, so the latest financial report is the best representation of the company’s current financial status. Check when Progressive Care's financial data was last updated here.
  • Explore more healthy companies in the Consumer Retailing industry.

Dividend

What is Progressive Care's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate RXMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate RXMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if RXMD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if RXMD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of RXMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.3yrs

Average management tenure


CEO

Shital Mars

4.33yrs

Tenure

Ms. Shital Parikh Mars has been the Chief Executive Officer of Progressive Care, Inc. since January 4, 2016 and served as its Chief Operating Officer until January 4, 2016. Ms. Mars serves as Director of P ...


Leadership Team

NamePositionTenureCompensationOwnership
Alan Weisberg
Chairman & CFO7.33yrsUS$68.00kno data
Shital Mars
CEO & Director4.33yrsno datano data
Birute Norkute
Chief Operating Officer0.33yrno datano data

4.3yrs

Average Tenure

Experienced Management: RXMD's management team is considered experienced (4.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Alan Weisberg
Chairman & CFO7.33yrsUS$68.00kno data
Shital Mars
CEO & Director4.33yrsno datano data
Oleg Firer
Independent Director2.58yrsno datano data
Jervis Hough
Independent Director2.75yrsno datano data

2.8yrs

Average Tenure

Experienced Board: RXMD's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 5.1%.


Top Shareholders

Company Information

Progressive Care, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Progressive Care, Inc.
  • Ticker: RXMD
  • Exchange: OTCPK
  • Founded: 2005
  • Industry: Drug Retail
  • Sector: Consumer Retailing
  • Market Cap: US$22.393m
  • Shares outstanding: 453.30m
  • Website: https://progressivecareus.com

Location

  • Progressive Care, Inc.
  • 400 Ansin Boulevard
  • Suite A
  • Hallandale Beach
  • Florida
  • 33009
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RXMDOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDOct 2010

Biography

Progressive Care, Inc., through its subsidiary, Pharmco, LLC, provides prescription pharmaceuticals to individuals and institutions in south Florida. The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories; and the supply of various prescription medications to long term care facilities. It also provides long term care solutions to skilled nursing facilities, assisted living facilities, retirement centers and communities, doctors’ offices, and clinics. In addition, the company purchases, repackages, and dispenses prescription and non-prescription pharmaceutical products for its long term care customers. Further, it offers computerized maintenance of patient prescription histories; third party billing; and consultant pharmacist services consisting of evaluation of monthly patient drug therapy and monitoring the institution's drug distribution system, as well as home service and maintenance, defective product replacements, and free home installation and instruction services. Progressive Care, Inc. was founded in 2005 and is based in Hallandale Beach, Florida. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/05/29 14:19
End of Day Share Price2020/05/28 00:00
Earnings2012/09/30
Annual Earnings2011/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.